Characterization of diorganotin(IV) complexes with captopril. The first crystallographically authenticated metal complex of this anti-hypertensive agent

J Inorg Biochem. 2003 Dec 1;97(4):370-6. doi: 10.1016/s0162-0134(03)00309-x.

Abstract

Diorganotin(IV) complexes R(2)Sn(cap) (capH(2)=N-[(S)-3-mercapto-2-methylpropionyl]-L-proline; R=Me, Et, n-Bu and t-Bu) were prepared and characterised. The FTIR and Raman spectra demonstrated that the organotin(IV) moieties interact with the [S] atom of the ligand, while the other coordination sites are the carboxylate and the amide -CO groups. Mössbauer Delta data showed that the diorganotin(IV) compounds adopt slightly distorted trigonal-bipyramidal (tbp) geometry. A single-crystal X-ray study was performed on the compound Me(2)Sn(cap): the Sn atom is five-coordinated in a distorted tbp environment, with two [O] atoms in the axial positions and the [S] and two [C] atoms in the equatorial (eq) plane. Each cap ligand coordinates to two different Sn atoms, and infinite zigzag chains are formed, directed parallel to each other and to the b axis of the unit cell. NMR (CDCl(3)) of the Me(2)Sn(IV) and n-Bu(2)Sn(IV) complexes indicated the presence of different oligomeric species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents / chemistry*
  • Captopril / chemistry*
  • Crystallography, X-Ray
  • Magnetic Resonance Spectroscopy / methods
  • Models, Molecular
  • Organotin Compounds / chemistry*
  • Spectroscopy, Fourier Transform Infrared
  • Spectroscopy, Mossbauer
  • Spectrum Analysis, Raman

Substances

  • Antihypertensive Agents
  • Organotin Compounds
  • Captopril